Evidence map›Paper›PMID 33285245›Full record

ArticleMolecular and cellular endocrinology2021

Chronic circadian shift leads to adipose tissue inflammation and fibrosis.

Xuekai Xiong, Yayu Lin, Jeongkyung Lee, Antonio Paul, Vijay Yechoor, Mariana Figueiro, Ke Ma

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Xuekai XiongDepartment of Diabetes Complications & Metabolism, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
Yayu LinDepartment of Diabetes Complications & Metabolism, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
Jeongkyung LeeDiabetes and Beta Cell Biology Center, Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
Antonio PaulDepartment of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, 12208, USA.
Vijay YechoorDiabetes and Beta Cell Biology Center, Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
Mariana FigueiroLighting Research Center, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.
Ke MaDepartment of Diabetes Complications & Metabolism, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA. Electronic address: kema@coh.org.
City of Hope · USUniversity of Pittsburgh · USAlbany Medical Center Hospital · USRensselaer Polytechnic Institute · US

Funding

Lighting interventions to reduce circadian disruption in rotating shift workersR01OH010668 · OH · RENSSELAER POLYTECHNIC INSTITUTE · PI FIGUEIRO, MARIANA GROSS · 2015 to 2018
$2.2M
Circadian disruption-induced mitochondrial dysfunction in diabetesR01DK130499 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YECHOOR, VIJAY K · 2021 to 2024
$1.8M
Circadian Clock Control of Adipose Depot Development and FunctionR01DK112794 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI MA, KE · 2018 to 2021
$1.7M
Circadian Clock and Beta Cell Stress AdaptationR01DK097160 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YECHOOR, VIJAY K · 2014 to 2018
$1.7M
ACL HHS R01OH010668NIDDK NIH HHS R01 DK097160NIDDK NIH HHS R01 DK112794NIDDK NIH HHS R01 DK130499NIOSH CDC HHS R01 OH010668
6 · The paper itself

Abstract

The circadian clock exerts temporal coordination of metabolic pathways. Clock disruption is intimately linked with the development of obesity and insulin resistance, and our previous studies found that the essential clock transcription activator, Brain and Muscle Arnt-like 1 (Bmal1), is a key regulator of adipogenesis. However, the metabolic consequences of chronic shiftwork on adipose tissues have not been clearly defined. Here, using an environmental lighting-induced clock disruption that mimics rotating shiftwork schedule, we show that chronic clock dysregulation for 6 months in mice resulted in striking adipocyte hypertrophy with adipose tissue inflammation and fibrosis. Both visceral and subcutaneous depots display enlarged adipocyte with prominent crown-like structures indicative of macrophage infiltration together with evidence of extracellular matrix remodeling. Global transcriptomic analyses of these fat depots revealed that shiftwork resulted in up-regulations of inflammatory, adipogenic and angiogenic pathways with disruption of normal time-of-the-day-dependent regulation. These changes in adipose tissues are associated with impaired insulin signaling in mice subjected to shiftwork, together with suppression of the mTOR signaling pathway. Taken together, our study identified the significant adipose depot dysfunctions induced by chronic shiftwork regimen that may underlie the link between circadian misalignment and insulin resistance.

Indexed as

PhotoperiodAdipocytesAdipogenesisAdipose TissueAnimalsCircadian ClocksDown-RegulationFibrosisGene Expression ProfilingGene Expression RegulationGene OntologyInflammationInsulin ResistanceMacrophagesMaleMicemTOR protein, mouseTOR Serine-Threonine KinasesAdipose tissueCircadian clockInflammationInsulin resistanceShiftwork

Identifiers

PMID33285245
PMCPMC7799174
OpenAlexW3107860081

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.